NASP

Registration Opens for the National Association of Specialty Pharmacy 2024 Annual Meeting & Expo

Retrieved on: 
Tuesday, March 12, 2024
Convention center, Pharmacist, Annual, Organ transplantation, Rheumatoid arthritis, CE, Woman, Multiple sclerosis, Haemophilia, Pharmacy, Patient, Cancer, Abstract, Love, Specialty pharmacy, National Association, CSP, Cell, Data management, Nursing, Education, NASP, Consultant, Cystic fibrosis, Accreditation, Hospital

Washington, DC, March 12, 2024 (GLOBE NEWSWIRE) -- Today, the National Association of Specialty Pharmacy (NASP), the only industry association in the U.S. whose membership includes all specialty pharmacy stakeholders, opened registration for the NASP 2024 Annual Meeting & Expo, to be held October 6 - 9, 2024, at the Gaylord Opryland Resort & Convention Center in Nashville, TN.

Key Points: 
  • Washington, DC, March 12, 2024 (GLOBE NEWSWIRE) -- Today, the National Association of Specialty Pharmacy (NASP), the only industry association in the U.S. whose membership includes all specialty pharmacy stakeholders, opened registration for the NASP 2024 Annual Meeting & Expo, to be held October 6 - 9, 2024, at the Gaylord Opryland Resort & Convention Center in Nashville, TN.
  • “The NASP 2024 Annual Meeting & Expo offers everything that attendees have come to love and expect, including top-of-class educational content and networking events.
  • Workshops include Accreditation, Cell & Gene Therapy, Certified Specialty Pharmacist (CSP) Exam Prep Course, Hospital/Health System Specialty Pharmacy, Specialty Pharmacy Law, and Technology.
  • The Annual Meeting & Expo also features a showcase for specialty pharmacy clinical research with its abstract and poster program.

VocoVision Clinical Team Members to Showcase Expertise at National Association of School Psychology Convention

Retrieved on: 
Wednesday, February 7, 2024
Internet, Education, School, Knowledge, Student, Mental health, NASP, National Association, Convention, Nursing

ATLANTA, GA., Feb. 07, 2024 (GLOBE NEWSWIRE) -- VocoVision, a leader in telepractice for U.S. schools, is proud to announce that two clinical team members will be presenting at the National Association of School Psychology (NASP) Convention this year.

Key Points: 
  • ATLANTA, GA., Feb. 07, 2024 (GLOBE NEWSWIRE) -- VocoVision, a leader in telepractice for U.S. schools, is proud to announce that two clinical team members will be presenting at the National Association of School Psychology (NASP) Convention this year.
  • The convention is the largest annual gathering of school psychologists and other related professionals in the world.
  • “We are thrilled to have two of our clinical team members, Kylie Miller and Kathryn Steele, presenting at the National Association of School Psychology (NASP) Convention,” said Jessica Marlow, Vice President at VocoVision.
  • We invite you to connect with us at the National Association of School Psychology (NASP) Convention by participating in the presentations listed above or stopping by our exhibitor booth #1202 to grab free swag and connect with our team of account executives.

Riverside Insights and CAI Founders to Host Virtual Conference on SLD Identification

Retrieved on: 
Tuesday, November 28, 2023
CAI, Genetics, NASP, Continuing education, Cognitive neuroscience, WJ, Neuropsychology, Mathematics, APA, Single Supervisory Mechanism, Intervention, Unified, Better, Learning, National Association, Report, Practice, Conference, Riverside Insights, American Psychological Association, SLD, Conjugated estrogens, Art, Nursing, Tutoring, Education, Research, Intelligence

ITASCA, Ill., Nov. 28, 2023 /PRNewswire-PRWeb/ -- Riverside Insights®, a leading developer of research-based assessments and analytics, today announced it is teaming up with Dr. Dawn P. Flanagan, Dr. Vincent C. Alfonso and Dr. Samuel O. Ortiz, creators of the Cross-Battery Assessment Approach and founders of Comprehensive Assessment for Intervention (CAI), to host their first annual virtual conference featuring researchers, scholars, and educators dedicated to advancing the field of specific learning disabilities (SLD) identification and intervention. The CAI Conference - State of the Art of SLD Identification: Innovations in Theory, Research, and Practice - will take place January 25-26, 2024, and enable participants to earn continuing education (CE) credit.

Key Points: 
  • Dawn P. Flanagan, Dr. Vincent C. Alfonso and Dr. Samuel O. Ortiz, creators of the Cross-Battery Assessment Approach and founders of Comprehensive Assessment for Intervention (CAI), to host their first annual virtual conference featuring researchers, scholars, and educators dedicated to advancing the field of specific learning disabilities (SLD) identification and intervention.
  • The CAI Conference - State of the Art of SLD Identification: Innovations in Theory, Research, and Practice - will take place January 25-26, 2024, and enable participants to earn continuing education (CE) credit.
  • CAI 2024 brings together a premier line-up of world-renowned presenters including researchers, scholars, and educators dedicated to advancing the field of SLD identification and intervention.
  • "CAI 2024 brings together a premier line-up of world-renowned presenters including researchers, scholars, and educators dedicated to advancing the field of SLD identification and intervention," said Dr. Sarah Holman, director, Riverside Insights.

NASP Applauds the Senate Finance Committee for Taking Additional Steps to Address Anticompetitive PBM Practices

Retrieved on: 
Wednesday, November 8, 2023
National Association, Insurance, DIR, NASP, Haemophilia, Rare, Committee, Legislation, Meat extenders, Acquisition, Accreditation, Rheumatoid arthritis, Health, Maintenance, Administration, United States Senate Finance Subcommittee on Health Care, Medicare Part D, Growth, Organ transplantation, Pharmacy, Cystic fibrosis, Specialty pharmacy, Multiple sclerosis, House, Cancer, Patient, Senate, Hospital, Medicare, Medicaid

Washington, DC, Nov. 08, 2023 (GLOBE NEWSWIRE) -- The National Association of Specialty Pharmacy (NASP) thanks the Senate Finance Committee for its bipartisan efforts to address anticompetitive practices that ultimately harm beneficiary access to the specialty pharmacy of their choice.

Key Points: 
  • Washington, DC, Nov. 08, 2023 (GLOBE NEWSWIRE) -- The National Association of Specialty Pharmacy (NASP) thanks the Senate Finance Committee for its bipartisan efforts to address anticompetitive practices that ultimately harm beneficiary access to the specialty pharmacy of their choice.
  • Today’s legislation includes efforts to strengthen and enforce the long-standing federal Any Willing Pharmacy law, an NASP advocacy priority.
  • For these beneficiaries, their pharmacies meet the patients where they are in their local communities, but typically operate from a centralized location.
  • Specialty pharmacies are accredited by an independent, third party nationally recognized accreditation organization ensuring consistent quality of extensive drug management and clinical patient care services.

Wex Photo Video launches programme to make photography available on prescription for those struggling with mental health

Retrieved on: 
Tuesday, October 3, 2023
Daniel, National Academy for Social Prescribing, Housing, Depression, Life, A&E, Anxiety, Emotion, Loneliness, Photography, Science, Gardening, NASP, National academy, Sonic Arts Network, Patient, Cooking, Social, NHS, Research, Health, Mental health, PTSD, Nursing, Camera, Canon

Through the 'Photography on Prescription' programme, patients and community groups will access equipment provided by Wex and photography masterclasses with the goal of improving their mental health.

Key Points: 
  • Through the 'Photography on Prescription' programme, patients and community groups will access equipment provided by Wex and photography masterclasses with the goal of improving their mental health.
  • Whilst photography will never be the total solution, we hope that this project will help some people who are currently struggling."
  • Their ambition is to expand the 'Photography on prescription' programme to partner with more community groups and add to their online resources.
  • For more information on Wex Events and how to use photography as a therapeutic tool, please visit the website here .

AIS Healthcare Leadership Featured at NASP 2023 Annual Meeting and Expo

Retrieved on: 
Monday, September 25, 2023
General Health, Pharmaceutical, Health, Parkland Health & Hospital System, TDD, Doctor of Pharmacy, Pharmacy, CNSC, Ochsner Health System, Baylor Scott & White Health, Pharmacopoeia, MBA, AIS, USP, Pharmacist, NASP, Specialty pharmacy, Guideline, Patient, Category 3, Special Program of Assisted Reproduction, CPPS, National Association, Safety, Medical device, Hospital

AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, announced its participation in the National Association of Specialty Pharmacy (NASP) 2023 Annual Meeting and Expo, which took place on September 18th – 21st in Grapevine, Texas.

Key Points: 
  • AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, announced its participation in the National Association of Specialty Pharmacy (NASP) 2023 Annual Meeting and Expo, which took place on September 18th – 21st in Grapevine, Texas.
  • At the NASP 2023 Annual Meeting and Expo, AIS Healthcare sponsored a continuing education symposium through an unrestricted educational grant that focused on the critical topic of USP 797 guideline revisions, a set of standards developed by U.S. Pharmacopeia (USP) governing the safe compounding of sterile preparations in healthcare settings, and its impact on the healthcare industry.
  • AIS Healthcare is honored to have participated in the NASP 2023 Annual Meeting and Expo and is committed to fostering innovation and excellence in pharmaceutical compounding.
  • For more information about the NASP 2023 Annual Meeting and Expo, please visit www.naspmeeting.com .

National Association of Specialty Pharmacy (NASP) Welcomes New Board Chairman, New Board Members, and Congratulates Award Winners at its Record-Breaking 2023 Annual Meeting & Expo

Retrieved on: 
Thursday, September 21, 2023
Community Oncology Alliance, Walgreen, MBA, Australian Book Industry Awards, Specialty pharmacy, Patient, West Virginia University Health System, Digital, Health, Convention center, CSP, Pharmacist, Collection, University, Impact, Gaylord Texan Resort Hotel & Convention Center, Research, Organization, PAN Foundation, Abstract, BCPS, Cost, Distinguished Service Award, University of Mississippi School of Engineering, Ernst & Young Entrepreneur of the Year Award, Hepatitis C, NASP, Student, Pharmacy technician, Diabetes, University of Mississippi Medical Center, Hospital, Nursing, Pharmacy, Doctor of Pharmacy, Pfizer

He also thanked the board members who are concluding their terms for their long-standing service to NASP.

Key Points: 
  • He also thanked the board members who are concluding their terms for their long-standing service to NASP.
  • Their unwavering dedication shaped the future of not only NASP but also the specialty pharmacy industry,” said Mr. Skiermont.
  • In addition to celebrating new board members, a total of eight industry award winners, four poster award winners, and three scholarship recipients were announced.
  • The new board members, Industry Award winners, Poster award winners, and Scholarship Award winners were all recognized during the meeting to a record audience of more than 1,600 attendees.

Walgreens, AllianceRx Walgreens Pharmacy Study of Non-Infused Biologics in Rheumatoid Arthritis Treatment Underscores Importance of Medication Adherence

Retrieved on: 
Wednesday, September 20, 2023
Deformity, Pharmacy, Doctor of Pharmacy, RA, PQA, Hospital, Supplement, Medicine, Research, Inflammation, Doctor of Philosophy, NASP, Encounter, Pharmacist, PDC, Patient, Length of stay, Immune system, Rheumatoid arthritis, Joint, Poster, PDF, Chronic pain, CSP, Nursing, Walgreens

ORLANDO, Fla., Sept. 20, 2023 /PRNewswire/ -- A recent study evaluating the use of non-infused biologics in patients diagnosed with rheumatoid arthritis (RA) demonstrated that patients who are adherent to their non-infused RA biologic medication are more likely to have lower medical costs, odds of hospitalization and length of stay (LOS). AllianceRx Walgreens Pharmacy, a leading specialty and home delivery pharmacy, and Walgreens, one of the largest drug store chains in the U.S., conducted the retrospective cohort study.

Key Points: 
  • AllianceRx Walgreens Pharmacy , a leading specialty and home delivery pharmacy, and Walgreens , one of the largest drug store chains in the U.S., conducted the retrospective cohort study .
  • The Pharmacy Quality Alliance (PQA) promotes a useful reporting metric of proportion of days covered (PDC) for non-infused biologic medications to treat RA.
  • Renee Baiano, PharmD, CSP , clinical program manager for AllianceRx Walgreens Pharmacy and an author of the study, says the research findings underscore the importance of patients remaining adherent to their therapy.
  • "Identifying barriers to adherence and educating patients on the importance of taking their medication can increase the patient's chance at disease improvement," says Dr. Baiano.

Fin Capital Announces Formation of Advisory Board

Retrieved on: 
Tuesday, September 12, 2023
Banking, Fintech, Professional Services, Finance, Diamond, NASP, SK, Senior, Committee, SGX, Investment, Robotics, Capital, Principal, National Association, CPO, Boston Consulting Group, Risk, HKSE, Risk management, Banque Indosuez, Government, USRobotics, Partner, Knowledge, Growth, Security (finance), CIO, Harbert Management Corporation, Apollo Global Management, 3Com, Norwest Venture Partners, Citigroup, Engineering, Merrill (company), GIC, Information technology, Financial services, Senior advisor, Performance management, Stanford University, Boston, Private limited company, Yucaipa Companies, Harvard Innovation Labs, Mastercard, Hertz, SEI, Freeman Vineyard & Winery, Cryptocurrency, Management, Governance

Fin Capital , a global asset manager specializing in B2B FinTech, today announced the launch of its advisory board.

Key Points: 
  • Fin Capital , a global asset manager specializing in B2B FinTech, today announced the launch of its advisory board.
  • Comprised of leaders across several investment and operating disciplines, the board will provide important support to both the firm and its portfolio companies.
  • The advisory board will aid and assist Fin Capital's investment and platform teams in evaluating investment opportunities, business development across the firm's multi-stage portfolios, and adding talent to underlying management teams.
  • Jordi Nieto Gabarró: Founder and CEO of Crillon Capital Partners (Former Sabertia Capital Partners), a leading investment banking boutique with a presence in more than 20 countries.

Shields Health Solutions Consistently Demonstrates Superior Clinical Outcomes

Retrieved on: 
Tuesday, September 12, 2023
AIDS, Health, Physical Therapy, Other Health, Managed Care, General Health, Pharmaceutical, Insurance, Flare, RA, Doctor of Pharmacy, HIV, Pharmacy, Disability, Research, Multiple sclerosis, Hepatitis C, MS, CDC, NASP, Literature, Hospital, Specialty pharmacy, Patient, ARR, Diagnosis, National Association, Pharmaceutical industry, Health insurance, Nursing, Shield

Shields Health Solutions (Shields), the premier specialty pharmacy accelerator in the country, recently published its latest patient outcomes in key disease states such as hepatitis C, HIV, rheumatoid arthritis (RA), and multiple sclerosis (MS).

Key Points: 
  • Shields Health Solutions (Shields), the premier specialty pharmacy accelerator in the country, recently published its latest patient outcomes in key disease states such as hepatitis C, HIV, rheumatoid arthritis (RA), and multiple sclerosis (MS).
  • Through collaboration with its health system partners nationwide, these industry-leading patient outcomes further illustrate the effectiveness of Shields’ integrated care model.
  • “We are thrilled to reinforce our reputation as the nation’s leading specialty pharmacy partner through our exceptional outcomes in various complex disease states,” said Brian S. Smith, PharmD, Chief Pharmacy Officer at Shields.
  • Furthermore, 93% of Shields patients reported their condition improved or stabilized since receiving care through the network of integrated health system specialty pharmacies.